Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
Table 2
Dose of dulaglutide and semaglutide at baseline and 3 months and 6 months after switching. (a) Study 1. (b) Study 2.